| 2967 |
Plasminogen activator inhibitor-1 deficiency, SERPINE1-related |
1 |
Drug
|
75.5 |
| 2976 |
Macular dystrophy, BEST1-related |
1 |
Target evidence
|
58.6 |
| 3010 |
Polyglucosan body myopathy, RBCK1-related |
1 |
Target evidence
|
62.9 |
| 3011 |
Ichthyosis, ALOXE3-related |
1 |
Human gene
|
34.0 |
| 3025 |
Cerebellar abiotrophy, CACNA2D2-related |
1 |
Human gene
|
29.0 |
| 3026 |
Porencephaly, SLC25A12-related |
1 |
Target evidence
|
57.0 |
| 3028 |
Retinal atrophy, cone-rod dystrophy, SPATA7-related |
1 |
Target evidence
|
54.6 |
| 3031 |
Deafness, LHFPL5-related |
1 |
Human gene
|
29.0 |
| 3038 |
Paw pad hyperkeratosis, GJB6-related |
1 |
Target evidence
|
57.9 |
| 3039 |
Curly coat, KRT25-related |
1 |
Target evidence
|
53.0 |
| 3044 |
Osteogenesis imperfecta, BMP1-related |
1 |
Human gene
|
34.0 |
| 3045 |
Autoimmune lymphoproliferative syndrome, FAS-related |
1 |
Target evidence
|
59.9 |
| 3046 |
Retinal atrophy, progressive, CACNA1F-related |
1 |
Drug
|
59.6 |
| 3047 |
Polycystic kidney disease, GANAB-related |
1 |
Target evidence
|
61.7 |
| 3048 |
Vestibular disease, PCDH15-related |
1 |
Target evidence
|
54.7 |
| 3053 |
Neuropsychiatric disorder risk factor, DISC1-related |
2 |
Human gene
|
29.0 |
| 3056 |
Myopathy, creatine deficiency disorder, GATM-related |
1 |
Target evidence
|
58.6 |
| 3057 |
Cerebellar atrophy, EMC1-related |
1 |
Target evidence
|
60.9 |
| 3058 |
Ataxia, SETX-related |
1 |
Target evidence
|
58.1 |
| 3059 |
Hypothyroidism and dwarfism, TG-related |
1 |
Human gene
|
29.0 |
| 3061 |
Leukoencephalomyelopathy, NECAP1-related |
1 |
Human gene
|
34.0 |
| 3072 |
Polysynovitis, HYAL1-related |
1 |
Target evidence
|
56.3 |
| 3080 |
Dystroglycanopathy, POMT1-related |
1 |
Target evidence
|
57.8 |
| 3081 |
Usher syndrome, WHRN-related |
1 |
Target evidence
|
53.8 |
